Cancer Family
Melanocytic Neoplasm
CI-CAN-00000026Explore in graph →
Non-malignant609 active trials13 approved drugs233 evidence items
- NCIt
- C7058
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000026Explore in graph →
Clinical trials
3,258 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01368276 | An Extended Use Study of Safety and Efficacy of Talimogene Laherparepvec in Melanoma | completed | Phase 3 | 31 | BioVex LimitedINDUSTRY | 2 | Dec 18, 2015 | clinicaltrials |
| NCT00477906 | M-Vax + Low Dose Interleukin-2 Versus Placebo Vaccine in Metastatic Melanoma in Patients With Stage IV Melanoma | unknown | Phase 3 | 387 | AVAX TechnologiesINDUSTRY | 0 | Dec 3, 2015 | clinicaltrials |
| NCT00110019 |
| Carboplatin and Paclitaxel With or Without Sorafenib Tosylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery |
| completed |
| Phase 3 |
| 823 |
| National Cancer Institute (NCI)NIH |
| 2 |
| Oct 19, 2015 |
| clinicaltrials |
| NCT00275496 | Multicenter Selective Lymphadenectomy Trial (MSLT) | completed | Phase 3 | 2,001 | Saint John's Cancer InstituteOTHER | 0 | Sep 2, 2015 | clinicaltrials |
| NCT01729663 | Phase II/III Clinical Study CSF470 Plus BCG Plus GM-CSF vs IFN Alpha 2b in Stage IIB, IIC and III Melanoma Patients | unknown | Phase 2 / Phase 3 | 108 | Laboratorio Pablo Cassara S.R.L.INDUSTRY | 1 | Sep 2, 2015 | clinicaltrials |
| NCT00006237 | S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma | completed | Phase 3 | 432 | SWOG Cancer Research NetworkNETWORK | 2 | Mar 25, 2015 | clinicaltrials |
| NCT00006249 | Interferon Alfa Following Surgery in Treating Patients With Stage III Melanoma | unknown | Phase 3 | 1,258 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 18 | Feb 10, 2015 | clinicaltrials |
| NCT00324155 | Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV Melanoma | completed | Phase 3 | 681 | Bristol-Myers SquibbINDUSTRY | 25 | Nov 3, 2014 | clinicaltrials |
| NCT00111007 | A Treatment Combination for Patients With Unresectable Stage III or Stage IV Melanoma | completed | Phase 3 | 270 | BayerINDUSTRY | 7 | Oct 31, 2014 | clinicaltrials |
| NCT00522834 | Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma | terminated | Phase 3 | 630 | Synta Pharmaceuticals Corp.INDUSTRY | 8 | Mar 4, 2014 | clinicaltrials |
| NCT00004196 | Interferon Alfa-2b in Treating Patients With Melanoma and Early Lymph Node Metastasis | completed | Phase 3 | 3,000 | University of Alabama at BirminghamOTHER | 1 | Jan 20, 2014 | clinicaltrials |
| NCT00002767 | Interferon Alfa With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma | unknown | Phase 3 | 300 | GlaxoSmithKlineINDUSTRY | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00016263 | Dacarbazine With or Without Oblimersen (G3139) in Treating Patients With Advanced Malignant Melanoma | completed | Phase 3 | — | Genta IncorporatedINDUSTRY | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00002892 | Interferon Alfa or No Further Therapy Following Surgery in Treating Patients With Stage II, Stage III, or Recurrent Melanoma | completed | Phase 3 | 1,000 | Institute of Cancer Research, United KingdomOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00039234 | Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Stage IV Melanoma Metastatic to the Liver | unknown | Phase 3 | — | Maxim PharmaceuticalsINDUSTRY | 4 | Dec 18, 2013 | clinicaltrials |
| NCT00395070 | A Phase 3 Pivotal Trial Comparing Allovectin-7® Alone vs Chemotherapy Alone in Patients With Stage 3 or Stage 4 Melanoma | completed | Phase 3 | 390 | VicalINDUSTRY | 14 | Sep 13, 2013 | clinicaltrials |
| NCT00002455 | Immunotherapy After Surgery in Treating Patients With Breast Cancer, Colon Cancer, or Melanoma | unknown | Phase 3 | — | Centro Oncologico de ExcelenciaOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT00003789 | Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Locally Advanced Melanoma of the Arm or Leg | completed | Phase 3 | 216 | National Cancer Institute (NCI)NIH | 1 | Jul 16, 2013 | clinicaltrials |
| NCT00287196 | Immediate Radiotherapy or Observation After Surgery for Melanoma Involving Lymph Nodes | completed | Phase 3 | 250 | Trans Tasman Radiation Oncology GroupOTHER | 4 | Jun 25, 2013 | clinicaltrials |
| NCT00072124 | Dacarbazine and/or Cisplatin Compared With Complete Metastasectomy in Treating Patients With Stage IV Melanoma | completed | Phase 3 | — | National Cancer Institute (NCI)NIH | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00671918 | Trial of Lymphoseek in Intraoperative Localization of Lymph Nodes in Breast Cancer and Melanoma | completed | Phase 3 | 186 | Navidea BiopharmaceuticalsINDUSTRY | 2 | Jun 17, 2013 | clinicaltrials |
| NCT01106040 | Breast and Melanoma Trial With Lymphoseek to Identify Lymph Nodes | completed | Phase 3 | 163 | Navidea BiopharmaceuticalsINDUSTRY | 1 | Jun 17, 2013 | clinicaltrials |
| NCT00447356 | High-Dose Interferon Alfa in Treating Patients With Stage II or StageIII Melanoma | withdrawn | Phase 3 | 0 | Hackensack Meridian HealthOTHER | 1 | May 13, 2013 | clinicaltrials |
| NCT01013623 | Stage IV Surgery Versus Best Medical Therapy(STG4SURG) | terminated | Phase 3 | 12 | Saint John's Cancer InstituteOTHER | 5 | Sep 26, 2012 | clinicaltrials |
| NCT00020839 | Temozolomide With or Without Radiation Therapy to the Brain in Treating Patients With Stage IV Melanoma That Is Metastatic to the Brain | terminated | Phase 3 | 23 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 11 | Sep 24, 2012 | clinicaltrials |
| NCT00036816 | Vaccine Therapy in Treating Patients With Melanoma of the Eye | terminated | Phase 3 | 13 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 2 | Sep 24, 2012 | clinicaltrials |
| NCT00110123 | Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye Melanoma | terminated | Phase 3 | 171 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 4 | Sep 24, 2012 | clinicaltrials |
| NCT00039000 | Study of Heat Shock Protein-Peptide Complex (HSPPC-96) Versus IL-2/DTIC for Stage IV Melanoma | completed | Phase 3 | 350 | Agenus Inc.INDUSTRY | 9 | Sep 7, 2012 | clinicaltrials |
| NCT00257205 | CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy | completed | Phase 3 | 655 | AstraZenecaINDUSTRY | 21 | Jul 2, 2012 | clinicaltrials |
| NCT00434057 | Evaluation of Pigmented Skin Lesions With MelaFind(R) System | completed | Phase 3 | 1,383 | MELA Sciences, Inc.INDUSTRY | 1 | Feb 14, 2012 | clinicaltrials |
| NCT00002882 | Interferon Alfa With or Without Combination Chemotherapy Plus Interleukin-2 in Treating Patients With Melanoma | completed | Phase 3 | 140 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 13, 2011 | clinicaltrials |
| NCT00002763 | High-Dose or Low-Dose Interferon Alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma | unknown | Phase 3 | 1,000 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 21 | Nov 16, 2011 | clinicaltrials |
| NCT00518895 | Trial of Dacarbazine With or Without Genasense in Advanced Melanoma(AGENDA) | completed | Phase 3 | 300 | Genta IncorporatedINDUSTRY | 12 | Nov 7, 2011 | clinicaltrials |
| NCT00094653 | MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma | completed | Phase 3 | 1,783 | Bristol-Myers SquibbINDUSTRY | 13 | Jul 11, 2011 | clinicaltrials |
| NCT01259934 | Nordic Adjuvant IFN Melanoma Trial | completed | Phase 3 | 855 | Karolinska InstitutetOTHER | 1 | Dec 14, 2010 | clinicaltrials |
| NCT00221702 | PegIntron Versus IntronA in CMAJCC Stage II (EADO 2001/CMII Trial)(EADO) | completed | Phase 3 | 898 | University Hospital, BordeauxOTHER | 1 | Oct 13, 2010 | clinicaltrials |
| NCT00811200 | Treatment Of Radiation Retinopathy Trial(TORR) | unknown | Phase 2 / Phase 3 | 220 | Leiden University Medical CenterOTHER | 0 | Jul 2, 2009 | clinicaltrials |
| NCT00005052 | Vaccine Therapy in Treating Patients With Primary Stage II Melanoma | unknown | Phase 3 | — | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 18 | Feb 9, 2009 | clinicaltrials |
| NCT00779714 | Comparative Study of Individualized Sensitivity-Directed Chemotherapy Versus DTIC(ChemoSensMM) | unknown | Phase 3 | 360 | University of WuerzburgOTHER | 1 | Oct 24, 2008 | clinicaltrials |
| NCT00003647 | Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma | completed | Phase 3 | — | VicalINDUSTRY | 1 | Jul 25, 2008 | clinicaltrials |
| NCT00001296 | A Randomized Phase III Trial of Hyperthermic Isolated Limb Perfusion With Melphalan, Tumor Necrosis Factor, and Interferon-Gamma in Patients With Locally Advanced Extremity Melanoma | completed | Phase 3 | 122 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00226408 | Standard High-Dose Alpha Interferon Versus Intermittent High-Dose Alpha Interferon | unknown | Phase 3 | 600 | Dermatologic Cooperative Oncology GroupOTHER | 1 | Jun 21, 2006 | clinicaltrials |
| NCT00052130 | Vaccine Therapy for Patients With Stage III Melanoma | unknown | Phase 3 | 1,118 | CancerVax CorporationINDUSTRY | 13 | Jun 24, 2005 | clinicaltrials |
| NCT00052156 | Vaccine Therapy for Patients With Stage IV Melanoma | unknown | Phase 3 | 670 | CancerVax CorporationINDUSTRY | 13 | Jun 24, 2005 | clinicaltrials |
| NCT00055562 | Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Melanoma | completed | Phase 2 / Phase 3 | 274 | Celgene CorporationINDUSTRY | 2 | Jun 24, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Dec 18, 2015source: clinicaltrials